JWJoanna Wrona

Joanna Wrona

*This is an algorithmically generated author record based on publicly available information.

Joanna Wrona has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MANAGEMENT OF ACUTE LIMB ISCHEMIA - THE REVIEW

    by Jędrzej Kęsik, Aleksandra Kaźmierczyk, Daria Madycka, Małgorzata Słaboń, Karol Stępniak, Wiktor Telega, Kinga Wnuczek, Joanna Wrona, Weronika Skrzypek, Julia Czerwik

    Acute limb ischemia (ALI) is a sudden reduction in limb perfusion that threatens limb viability and requires urgent intervention. It can present as an acute manifestation of peripheral arterial disease (PAD) or as an acute event in previously asymptomatic patients. This review outlines the epidemiology, pathophysiology, clinical features, diagnostic approaches, and current treatment strategies for ALI. Emphasis is placed on differentiating thrombotic and embolic causes, the use of imaging modalities such as CT angiography and duplex ultrasonography, and the application of the Rutherford classification to guide treatment decisions. Immediate systemic anticoagulation remains the cornerstone of early management, followed by either surgical revascularization or endovascular therapies. While open surgery remains standard in many cases, newer percutaneous mechanical thrombectomy systems (PMT) have emerged as effective alternatives, particularly in patients with contraindications to surgery or thrombolysis. Despite advances in diagnosis and therapy, ALI continues to carry a high risk of amputation and mortality.

  • Open Access

    OBSTRUCTIVE SLEEP APNEA AND ITS IMPACT ON ATHLETES AND SPORTS PERFORMANCE – THE REVIEW

    by Kinga Wiechnik, Joanna Wrona, Aleksandra Kaźmierczyk, Jędrzej Kęsik, Daria Madycka, Kacper Michta, Małgorzata Słaboń, Karol Stępniak, Wiktor Telega, Aleksandra Wójcik

    Obstructive sleep apnea (OSA) is a prevalent and underdiagnosed condition with significant systemic health implications. It is characterized by recurrent upper airway collapse during sleep, leading to intermittent hypoxia, sleep fragmentation, and an array of comorbidities. Among the risk factors, obesity is the most common, but other factors such as sex, age, tonsillar hypertrophy, and the presence of comorbid conditions also play a role. Untreated obstructive sleep apnea (OSA) can lead to cardiovascular diseases, diabetes, strokes, and even sudden death. Diagnosis is based on medical history, clinical examination, and most importantly, polysomnographic testing. Treatment includes lifestyle modifications, continuous positive airway pressure (CPAP) therapy, and in some cases, surgical interventions. This literature review synthesizes current evidence regarding the pathophysiology, clinical presentation, diagnostic approaches, and therapeutic options for OSA in adults.

  • Open Access

    LESCH – NYHAN SYNDROME (LNS) - THE REVIEW

    by Daria Madycka, Weronika Skrzypek, Małgorzata Słaboń, Karol Stępniak, Wiktor Telega, Kinga Wnuczek, Joanna Wrona, Aleksandra Kaźmierczyk, Jędrzej Kęsik

    Lesch-Nyhan syndrome (LNS) is a rare X-linked disorder caused by mutations in the HPRT1 gene, which encodes an important enzyme in the purine salvage pathway. Symptoms of LNS include dystonia, gout, intellectual disability, and self-harm. Although the disease was described in 1964, it remains unclear how abnormalities in hypoxanthine and guanine recycling can lead to such significant neurological deficits. Several studies have proposed different hypotheses regarding the etiology of the disease and various treatment options have been proposed, but none have led to a satisfactory explanation of the pathophysiology of the disease. New technologies such as sequencing, optogenetics, genome editing, and induced pluripotent stem cells may provide a unique opportunity to map the precise sequential pathways from genotype to disease phenotype.

  • Open Access

    FROM CHRONIC SINUSITIS TO SINONASAL TUMORS: THE EXPANDING ROLE OF FESS IN MODERN SURGERY

    by Aleksandra Kaźmierczyk, Jędrzej Kęsik, Daria Madycka, Małgorzata Słaboń, Karol Stępniak, Wiktor Telega, Kinga Wnuczek, Joanna Wrona, Weronika Skrzypek, Jan Wojtas

    Objective: The objective of this study was to explore the evolving role of Functional Endoscopic Sinus Surgery (FESS) - the gold standard in the treatment of chronic rhinosinusitis and other sinus diseases. Advances in diagnostic imaging, surgical instruments, and navigation systems have significantly improved the safety and efficacy of this technique. This study provides an overview of the FESS technique, and its expanding indications - application in the treatment of selected sinus tumors, such as inverted papilloma, juvenile nasopharyngeal angiofibroma (JNA), and osteomas. Methods: A narrative review of the literature was conducted, focusing on the development of FESS, its surgical technique, safety profile, and clinical outcomes. Special attention was given to its comparison with traditional open approaches in both inflammatory and neoplastic conditions of the sinonasal tract. Key Findings: The analysis revealed that technological progress - particularly in diagnostic imaging, surgical instruments, and intraoperative navigation - has significantly improved the precision and safety of FESS. Clinical evidence demonstrates that endoscopic resection of sinonasal tumors often achieves recurrence rates equal to or lower than those associated with open surgery, while minimizing morbidity, hospitalization time, and facial disfigurement. Successful outcomes depend on appropriate patient selection, meticulous preoperative planning, and the surgeon’s expertise. Conclusions: Functional Endoscopic Sinus Surgery is a safe and effective modality for treating a wide range of sinonasal diseases, including chronic rhinosinusitis and selected benign tumors. With proper patient selection, preoperative planning, and surgical expertise, FESS offers substantial benefits over traditional open approaches, including reduced morbidity and improved recovery. Continued technological advancements and long-term outcome studies will further refine its role in comprehensive sinonasal care.

  • Open Access

    THE USE OF BOTULINUM TOXIN AND ITS ROLE IN PAIN MANAGEMENT- A SYSTEMATIC REVIEW

    by Małgorzata Słaboń, Karol Stępniak, Wojciech Gąska, Joanna Wrona, Daria Madycka, Kinga Wnuczek, Wiktor Telega, Weronika Skrzypek, Jędrzej Kęsik, Aleksandra Kaźmierczyk

    Introduction and Purpose: For many decades, botulinum toxin has been used in various fields of medicine, from aesthetic procedures to urology and neurology. It has become a highly effective and important therapeutic tool in the hands of a qualified physician. The aim of this article is to provide an overview of current research on the use of botulinum toxin in medicine, with a particular focus on its role in the treatment of various types of pain. Materials and Methods: A literature review was conducted using the PubMed and Google Scholar databases. Relevant keywords were used as search terms. Conclusion: Botulinum toxin, a neurotoxin with a good safety profile, is used in numerous branches of medicine and plays an increasingly important role in the treatment of various pain conditions. This review presents the current state of knowledge on the mechanism of action and analgesic properties of botulinum toxin and highlights its promising potential in the development of new therapeutic methods.

  • Open Access

    Atopic dermatitis - the review

    by Joanna Wrona, Aleksandra Kaźmierczyk, Jędrzej Kęsik, Daria Madycka, Kacper Michta, Małgorzata Słaboń, Aleksandra Wójcik, Karol Stępniak, Wiktor Telega, Kinga Wnuczek

    Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by a disrupted epidermal barrier, immune dysregulation, and genetic predisposition. Affecting individuals across all age groups, AD presents with recurrent flare-ups and varying clinical patterns depending on age. The pathophysiology involves key elements such as loss-of-function mutations in the filaggrin (FLG) gene, overproduction of cytokines like IL-4 and IL-13, and skin colonization by Staphylococcus aureus. Management strategies include patient education, topical therapies (e.g., corticosteroids, calcineurin inhibitors, crisaborole, and tapinarof), systemic treatments like dupilumab and methotrexate, and phototherapy for refractory cases. Preventive measures, including breastfeeding and probiotic supplementation, offer limited benefits, emphasizing the need for individualized approaches. Innovative therapies and further research into AD pathogenesis hold promise for more effective disease control and improved quality of life for patients.

  • Open Access

    Deep vein thrombosis - the review

    by Karol Stępniak, Wiktor Telega, Kinga Wnuczek, Joanna Wrona, Aleksandra Kaźmierczyk, Jędrzej Kęsik, Daria Madycka, Kacper Michta, Małgorzata Słaboń, Maciej Sobczyk

    Deep vein thrombosis impacts between 2.5% and 5% of a population. It mostly affects lower-extremity veins and presents itself as pain, swelling, tenderness, and erythema of an affected region. Thrombus forms when at least one factor from the Virchow's triad is present - vascular damage, venous stasis or hypercoagulability. A range of clinical manifestations is very wide, from asymptomatic to life-threatening course of the disease. Post-thrombotic syndrome is a frequent complication that results in venous hypertension, which leads to tissue edema, subcutaneous fibrosis, and subsequent ulceration. In the diagnostic process, predominantly D-dimer assay and ultrasonographic compression test are performed. Noninvasive treatment relies on anticoagulation therapy which is based on direct oral anticoagulants, parenteral anticoagulants, and vitamin K antagonists. In specific cases, there is an option of invasive treatment, which involves inserting a catheter into a vein with a thrombus. Afterward, a thrombus can be mechanically fragmented and aspired or dissolved with the use of a thrombolytic agent.


  • Open Access

    Acne vulgaris in adolescents – the review

    by Aleksandra Wójcik, Sylwiusz Niedobylski, Joanna Wrona, Daria Madycka, Kinga Wnuczek, Jakub Starownik, Kacper Michta

    Acne vulgaris is one of the most common chronic inflammatory skin disorders that affects almost 90% of the adolescents worldwide. Due to its effect on one’s appearance, it causes not only physical but also psychological consequences. The cause of acne involves increased sebum production, hyperkeratinisation of the follicle, bacterial colonization and inflammation, which result in formation of comedones, papules, pustules and nodules. Diet, Body Mass Index, hyperhidrosis and stress can be triggering factors. The pharmacological treatment of acne involves substances administered topically as well as orally. First line of treatment of mild-to-moderate acne involves topical benzoyl peroxide, retinoids, chemical peels, antibiotics and combinations of those agents. The treatment of moderate-to-severe or inflammatory acne consists of oral antibiotics, isotretinoin, oral contraceptives and spironolactone. New therapies are being investigated and show a great potential, however further research should be pursued in order to achieve long-lasting results of the treatment.